Akihiro Shioya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Akihiro Shioya has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Sohsuke Yamada
Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan
23 shared publications - Motona Kumagai
Department of Pathophysiological and Experimental Pathology, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan
7 shared publications Masafumi Inokuchi
6 shared publications- Hidetaka Uramoto
Department of Thoracic Surgery, Kanazawa Medical University, Ishikawa, Japan
5 shared publications - Jia Han
Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan
5 shared publications - Miyako Shimasaki
Department of Pathology 2, Kanazawa Medical University, Daigaku 1-1, Uchinada-machi, Kahoku-gun 920-0293, Japan
5 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Elsevier in Regenerative Therapy
- Vol. 33
Ethanol-induced alterations in mesenchymal stromal cells and the effects of aspalathin: implications for alcohol-associated osteonecrosis
- 3 November 2026
- Published by Elsevier in Regenerative Therapy
- Vol. 33
Open AccessEthanol-induced alterations in mesenchymal stromal cells and the effects of aspalathin: implications for alcohol-associated osteonecrosis
- Open Access
- 13 October 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (10) , 1488
Glyceraldehyde May Induce the Generation of High-Molecular-Weight Species of HSP90β and Autophagy-Related Proteins and Alter Protein Levels in Human Renal Epithelial Cells
Kidney disease (KD) is a major health problem, and metabolic disorders contribute to diabetic nephropathy and chronic kidney disease, in which renal epithelial cell dysfunction plays an important role. Intracellular advanced glycation end-products (AGEs) may contribute to KD progression by disrupting cellular homeostasis; however, the underlying mechanisms remain unclear. Therefore, we aimed to investigate the effects of glyceraldehyde (GA) on molecular chaperone- and autophagy-related proteins in human renal epithelial cells (HK-2), with particular attention to AGE-related processes. Administration of high-fructose corn syrup to healthy Wistar rats increased argpyrimidine immunoreactivity in the renal tubular epithelial cells, compared with that in controls, suggesting enhanced accumulation of this GA-related AGE in vivo. In HK-2 cells, GA treatment caused concentration-dependent reductions in NADPH and ATP levels, accompanied by morphological changes. High molecular weight (HMW) immunoreactive species of HSP90β, Beclin-1, and ATG7 appeared following GA treatment. GA at 1.5 mM increased LC3-I, LC3-II, and p62 levels, whereas treatment with 2 mM GA attenuated these increases. Aminoguanidine, an inhibitor of AGE formation, attenuated these GA-induced alterations. Overall, GA may induce the generation of HMW species of HSP90β and autophagy-related proteins and may contribute to altered cellular homeostasis, with AGE-related processes potentially contributing to these effects.
- 13 October 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (10) , 1488
Open AccessGlyceraldehyde May Induce the Generation of High-Molecular-Weight Species of HSP90β and Autophagy-Related Proteins and Alter Protein Levels in Human Renal Epithelial Cells
Kidney disease (KD) is a major health problem, and metabolic disorders contribute to diabetic nephropathy and chronic kidney disease, in which renal epithelial cell dysfunction plays an important role. Intracellular advanced glycation end-products (AGEs) may contribute to KD progression by disrupting cellular homeostasis; however, the underlying mechanisms remain unclear. Therefore, we aimed to investigate the effects of glyceraldehyde (GA) on molecular chaperone- and autophagy-related proteins in human renal epithelial cells (HK-2), with particular attention to AGE-related processes. Administration of high-fructose corn syrup to healthy Wistar rats increased argpyrimidine immunoreactivity in the renal tubular epithelial cells, compared with that in controls, suggesting enhanced accumulation of this GA-related AGE in vivo. In HK-2 cells, GA treatment caused concentration-dependent reductions in NADPH and ATP levels, accompanied by morphological changes. High molecular weight (HMW) immunoreactive species of HSP90β, Beclin-1, and ATG7 appeared following GA treatment. GA at 1.5 mM increased LC3-I, LC3-II, and p62 levels, whereas treatment with 2 mM GA attenuated these increases. Aminoguanidine, an inhibitor of AGE formation, attenuated these GA-induced alterations. Overall, GA may induce the generation of HMW species of HSP90β and autophagy-related proteins and may contribute to altered cellular homeostasis, with AGE-related processes potentially contributing to these effects.
- 6 July 2026
- Published by Wiley in Diagnostic Cytopathology
- Vol. 54 (10) , 764-772
Clinical and Cytopathological Significance of Intracytoplasmic Lumina and Immunohistochemical Mucin Expression in Non‐Muscle‐Invasive Urothelial Carcinoma of the Bladder
Background: Intracytoplasmic lumina (ICL) are mucin‐containing structures identified in histological and cytological specimens of urothelial carcinoma and are associated with high‐grade tumors and poor prognosis. However, their biological significance remains unclear. This study investigated mucin expression in ICL and its association with clinical, cytopathological, and prognostic features in non‐muscle‐invasive urothelial carcinoma of the bladder. Methods: A total of 105 cases of non‐muscle‐invasive urothelial carcinoma of the bladder diagnosed were examined. Immunohistochemical staining for MUC1, MUC2, MUC4, MUC5AC, and MUC6 was performed in 47 cases in which ICL were identified histologically, and the staining patterns of ICL and tumor cells were evaluated. The presence of ICL in urine cytology specimens was assessed, and its associations with tumor‐specific survival and recurrence were analyzed statistically. Results: ICL were identified in 47 cases histologically and in 33 cases cytologically. ICL‐positive tumors were more frequently observed in high‐grade histology and were more often diagnosed as malignant or suspicious for malignancy in urine cytology. Immunohistochemically, MUC1 was the most frequently expressed mucin, with localization along the microvilli of the ICL lumen and within luminal mucin. Increased expression of MUC4 and MUC5AC showed a trend toward decreased survival. Conclusion: ICL in non‐muscle‐invasive urothelial carcinoma is more frequently observed in high‐grade tumors and shows characteristic mucin expression patterns, particularly MUC1 localization within ICL structures. Increased expression of MUC4 and MUC5AC may be associated with unfavorable clinical outcomes. These findings suggest that combined evaluation of ICL and mucin expression may provide additional prognostic information in urothelial carcinoma.
- 6 July 2026
- Published by Wiley in Diagnostic Cytopathology
- Vol. 54 (10) , 764-772
Clinical and Cytopathological Significance of Intracytoplasmic Lumina and Immunohistochemical Mucin Expression in Non‐Muscle‐Invasive Urothelial Carcinoma of the Bladder
Background: Intracytoplasmic lumina (ICL) are mucin‐containing structures identified in histological and cytological specimens of urothelial carcinoma and are associated with high‐grade tumors and poor prognosis. However, their biological significance remains unclear. This study investigated mucin expression in ICL and its association with clinical, cytopathological, and prognostic features in non‐muscle‐invasive urothelial carcinoma of the bladder. Methods: A total of 105 cases of non‐muscle‐invasive urothelial carcinoma of the bladder diagnosed were examined. Immunohistochemical staining for MUC1, MUC2, MUC4, MUC5AC, and MUC6 was performed in 47 cases in which ICL were identified histologically, and the staining patterns of ICL and tumor cells were evaluated. The presence of ICL in urine cytology specimens was assessed, and its associations with tumor‐specific survival and recurrence were analyzed statistically. Results: ICL were identified in 47 cases histologically and in 33 cases cytologically. ICL‐positive tumors were more frequently observed in high‐grade histology and were more often diagnosed as malignant or suspicious for malignancy in urine cytology. Immunohistochemically, MUC1 was the most frequently expressed mucin, with localization along the microvilli of the ICL lumen and within luminal mucin. Increased expression of MUC4 and MUC5AC showed a trend toward decreased survival. Conclusion: ICL in non‐muscle‐invasive urothelial carcinoma is more frequently observed in high‐grade tumors and shows characteristic mucin expression patterns, particularly MUC1 localization within ICL structures. Increased expression of MUC4 and MUC5AC may be associated with unfavorable clinical outcomes. These findings suggest that combined evaluation of ICL and mucin expression may provide additional prognostic information in urothelial carcinoma.
- Open Access
- 20 June 2026
- Published by Elsevier in Translational Oncology
- Vol. 71, 102865
PRDX4 expression potentially links redox adaptation to oncogenic signaling and tumor progression in pancreatic ductal adenocarcinoma
- 20 June 2026
- Published by Elsevier in Translational Oncology
- Vol. 71, 102865
Open AccessPRDX4 expression potentially links redox adaptation to oncogenic signaling and tumor progression in pancreatic ductal adenocarcinoma
- Open Access
- 1 June 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 10 (6) , e2600056
Clonal Evolution of Endometriosis to Peritoneal Endometrioid Carcinoma via PTEN Biallelic Inactivation: A Case Report With Integrated Genomic and Pathological Profiling
- 1 June 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 10 (6) , e2600056
Open AccessClonal Evolution of Endometriosis to Peritoneal Endometrioid Carcinoma via PTEN Biallelic Inactivation: A Case Report With Integrated Genomic and Pathological Profiling
- Open Access
EVG-Based Periarterial/Perivenous Invasion (periA/V) as a High-Sensitivity Surrogate Marker for Lymph Node Metastasis in pT1 Invasive Breast Carcinoma of No Special Type
Background/Objectives: Conventional assessments of lymphatic invasion in the primary tumor may fail to identify lymph node metastasis (LNM) in breast cancer. We evaluated periarterial or perivenous invasion (periA/V), using Elastica–van Gieson (EVG)-stained sections, as a histological marker associated with LNM in invasive breast carcinoma of no special type (IBC-NST), focusing on the impact of invasive tumor size. Methods: We retrospectively analyzed 213 IBC-NST cases. PeriA/V was defined as tumor nests in direct contact with perivascular elastic fibers on EVG-stained sections. Diagnostic performance was compared with that of conventional LI markers (hematoxylin and eosin and D2-40), with stratified analyses by pathological T category (pT1 vs. pT2–4) and pT1 subcategories (pT1a, pT1b, and pT1c). Results: LNM was observed in 87 cases (40.8%). Overall, periA/V demonstrated high sensitivity (97.7%) and negative predictive value (NPV; 93.5%). In pT1 tumors (n = 130), periA/V achieved 100% sensitivity and 100% NPV (27/27), and was consistently present in all node-positive pT1b–c tumors. In multivariate analyses, periA/V remained independently associated with LNM in the pT1 group (odds ratio [OR]: 16.08, p = 0.003) and pT1c subgroup (OR: 14.7, p = 0.010). In pT2–4 tumors, periA/V became frequent regardless of nodal status, indicating reduced discriminatory value. Conclusions: In this exploratory single-center cohort, EVG-based periA/V demonstrated high sensitivity for LNM in pT1 IBC-NSTs, with periA/V negativity consistently observed among node-negative cases. These preliminary findings suggest that periA/V may potentially contribute to LNM risk assessment in early-stage breast cancer.
Open AccessEVG-Based Periarterial/Perivenous Invasion (periA/V) as a High-Sensitivity Surrogate Marker for Lymph Node Metastasis in pT1 Invasive Breast Carcinoma of No Special Type
Background/Objectives: Conventional assessments of lymphatic invasion in the primary tumor may fail to identify lymph node metastasis (LNM) in breast cancer. We evaluated periarterial or perivenous invasion (periA/V), using Elastica–van Gieson (EVG)-stained sections, as a histological marker associated with LNM in invasive breast carcinoma of no special type (IBC-NST), focusing on the impact of invasive tumor size. Methods: We retrospectively analyzed 213 IBC-NST cases. PeriA/V was defined as tumor nests in direct contact with perivascular elastic fibers on EVG-stained sections. Diagnostic performance was compared with that of conventional LI markers (hematoxylin and eosin and D2-40), with stratified analyses by pathological T category (pT1 vs. pT2–4) and pT1 subcategories (pT1a, pT1b, and pT1c). Results: LNM was observed in 87 cases (40.8%). Overall, periA/V demonstrated high sensitivity (97.7%) and negative predictive value (NPV; 93.5%). In pT1 tumors (n = 130), periA/V achieved 100% sensitivity and 100% NPV (27/27), and was consistently present in all node-positive pT1b–c tumors. In multivariate analyses, periA/V remained independently associated with LNM in the pT1 group (odds ratio [OR]: 16.08, p = 0.003) and pT1c subgroup (OR: 14.7, p = 0.010). In pT2–4 tumors, periA/V became frequent regardless of nodal status, indicating reduced discriminatory value. Conclusions: In this exploratory single-center cohort, EVG-based periA/V demonstrated high sensitivity for LNM in pT1 IBC-NSTs, with periA/V negativity consistently observed among node-negative cases. These preliminary findings suggest that periA/V may potentially contribute to LNM risk assessment in early-stage breast cancer.
- Open Access
- 28 March 2026
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 27, e951744
Hormone Receptor–Positive Encapsulated Papillary Carcinoma of the Breast With High-Grade Cytological Features: A Case Report With Invasive Heterogeneity
BACKGROUND Encapsulated papillary carcinoma (EPC) with high-grade cytological features of the breast is an uncommon neoplasm characterized by aggressive biological behavior, histopathological heterogeneity, and a potential for invasion. Although typical EPCs usually present as low- to intermediate-grade lesions, those with high-grade cytological features are rare and poorly described in the literature. The diagnostic challenge lies in distinguishing these tumors from invasive papillary or ductal carcinomas and determining appropriate management strategies. CASE REPORT We describe the case of a 40-year-old woman who presented with a palpable lump in her right breast. Initial ultrasonography revealed a well-circumscribed 23-mm mass interpreted as benign, but follow-up imaging after 3 months showed rapid enlargement to 30 mm. Core needle biopsy confirmed invasive breast carcinoma of no special type. The patient underwent a skin-sparing mastectomy with immediate reconstruction. Histopathological examination revealed an EPC with high-grade cytological features, accompanied by high-grade and low-grade invasive components beyond the fibrous capsule. Immunohistochemically, the tumor was strongly positive for estrogen and progesterone receptors, negative for human epidermal growth factor receptor 2 (1+), and showed a high Ki-67 index (46.5%). The patient received adjuvant endocrine therapy and remains disease-free at the most recent follow-up. CONCLUSIONS This case illustrates the diagnostic and biological heterogeneity of hormone receptor-positive EPC with high-grade cytological features. Recognition of invasive components and accurate histopathological assessment are critical for proper classification and management. Given the presence of high-grade atypia, high mitotic activity, and a high proliferation index, such tumors should be managed according to the principles of invasive breast carcinoma.
- 28 March 2026
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 27, e951744
Open AccessHormone Receptor–Positive Encapsulated Papillary Carcinoma of the Breast With High-Grade Cytological Features: A Case Report With Invasive Heterogeneity
BACKGROUND Encapsulated papillary carcinoma (EPC) with high-grade cytological features of the breast is an uncommon neoplasm characterized by aggressive biological behavior, histopathological heterogeneity, and a potential for invasion. Although typical EPCs usually present as low- to intermediate-grade lesions, those with high-grade cytological features are rare and poorly described in the literature. The diagnostic challenge lies in distinguishing these tumors from invasive papillary or ductal carcinomas and determining appropriate management strategies. CASE REPORT We describe the case of a 40-year-old woman who presented with a palpable lump in her right breast. Initial ultrasonography revealed a well-circumscribed 23-mm mass interpreted as benign, but follow-up imaging after 3 months showed rapid enlargement to 30 mm. Core needle biopsy confirmed invasive breast carcinoma of no special type. The patient underwent a skin-sparing mastectomy with immediate reconstruction. Histopathological examination revealed an EPC with high-grade cytological features, accompanied by high-grade and low-grade invasive components beyond the fibrous capsule. Immunohistochemically, the tumor was strongly positive for estrogen and progesterone receptors, negative for human epidermal growth factor receptor 2 (1+), and showed a high Ki-67 index (46.5%). The patient received adjuvant endocrine therapy and remains disease-free at the most recent follow-up. CONCLUSIONS This case illustrates the diagnostic and biological heterogeneity of hormone receptor-positive EPC with high-grade cytological features. Recognition of invasive components and accurate histopathological assessment are critical for proper classification and management. Given the presence of high-grade atypia, high mitotic activity, and a high proliferation index, such tumors should be managed according to the principles of invasive breast carcinoma.
- Open Access
- 26 February 2026
- Published by MDPI AG in Preprints.org
EVG-Based Periarterial/Perivenous Invasion (periA/V) as a High-Sensitivity Surrogate Marker for Lymph Node Metastasis in pT1 Invasive Breast Carcinoma of No Special Type
Background/Objectives: Conventional lymphatic invasion assessments may fail to identify lymph node metastasis (LNM) in breast cancer. We evaluated periarterial or perivenous invasion (periA/V), using Elastica–van Gieson (EVG)-stained sections, as a histological marker associated with LNM in invasive breast carcinoma of no special type (IBC-NST), focusing on the impact of invasive tumor size. Methods: We retrospectively analyzed 213 IBC-NST cases. PeriA/V was defined as tumor nests in direct contact with perivascular elastic fibers on EVG-stained sections. Diagnostic performance was compared with that of conventional LI markers (hematoxylin and eosin and D2-40), with stratified analyses by pathological T category (pT1 vs. pT2–4) and pT1 subcategories (pT1a, pT1b, and pT1c). Results: LNM was observed in 87 cases (40.8%). Overall, periA/V demonstrated high sensitivity (97.7%) and negative predictive value (NPV; 93.5%). In pT1 tumors (n = 130), periA/V achieved 100% sensitivity and 100% NPV (27/27), and was consistently present in all node-positive pT1b–c tumors. In multivariate analyses, periA/V remained independently associated with LNM in the pT1 group (odds ratio [OR]: 16.08, P = 0.003) and pT1c subgroup (OR: 14.7, P = 0.010). In pT2–4 tumors, periA/V became frequent regardless of nodal status, indicating reduced discriminatory value. Conclusions: EVG-based periA/V is a robust and highly sensitive surrogate marker for LNM in small IBC-NSTs. In pT1 tumors, periA/V negativity effectively ruled out nodal involvement. Incorporating periA/V assessment may provide a cost-effective and objective approach for nodal risk stratification in early-stage breast cancer.
- 26 February 2026
- Published by MDPI AG in Preprints.org
Open AccessEVG-Based Periarterial/Perivenous Invasion (periA/V) as a High-Sensitivity Surrogate Marker for Lymph Node Metastasis in pT1 Invasive Breast Carcinoma of No Special Type
Background/Objectives: Conventional lymphatic invasion assessments may fail to identify lymph node metastasis (LNM) in breast cancer. We evaluated periarterial or perivenous invasion (periA/V), using Elastica–van Gieson (EVG)-stained sections, as a histological marker associated with LNM in invasive breast carcinoma of no special type (IBC-NST), focusing on the impact of invasive tumor size. Methods: We retrospectively analyzed 213 IBC-NST cases. PeriA/V was defined as tumor nests in direct contact with perivascular elastic fibers on EVG-stained sections. Diagnostic performance was compared with that of conventional LI markers (hematoxylin and eosin and D2-40), with stratified analyses by pathological T category (pT1 vs. pT2–4) and pT1 subcategories (pT1a, pT1b, and pT1c). Results: LNM was observed in 87 cases (40.8%). Overall, periA/V demonstrated high sensitivity (97.7%) and negative predictive value (NPV; 93.5%). In pT1 tumors (n = 130), periA/V achieved 100% sensitivity and 100% NPV (27/27), and was consistently present in all node-positive pT1b–c tumors. In multivariate analyses, periA/V remained independently associated with LNM in the pT1 group (odds ratio [OR]: 16.08, P = 0.003) and pT1c subgroup (OR: 14.7, P = 0.010). In pT2–4 tumors, periA/V became frequent regardless of nodal status, indicating reduced discriminatory value. Conclusions: EVG-based periA/V is a robust and highly sensitive surrogate marker for LNM in small IBC-NSTs. In pT1 tumors, periA/V negativity effectively ruled out nodal involvement. Incorporating periA/V assessment may provide a cost-effective and objective approach for nodal risk stratification in early-stage breast cancer.
- Open Access
- 1 January 2026
- Published by Japan Surgical Society in Surgical Case Reports
- Vol. 12 (1) , cr.25-0677
Primary Gastric Adenocarcinoma with Thyroid Transcription Factor-1 Positivity Mimicking Gastric Metastasis from Lung Cancer: A Case Report
INTRODUCTION: Thyroid transcription factor-1 (TTF-1) is a well-established immunohistochemical marker for tumors of lung and thyroid origin. Metastatic adenocarcinomas are often tested for TTF-1 expression to identify their primary site. Herein, we report a rare case of TTF-1–positive primary gastric adenocarcinoma that was initially misdiagnosed and treated as postoperative gastric metastasis from primary lung cancer.CASE PRESENTATION: A 58-year-old man underwent thoracoscopic right upper lobectomy with systemic lymph node dissection for lung cancer of the right upper lobe. The pathological diagnosis was invasive adenocarcinoma (pT2bN0M0, Stage IIA). He received 3 courses of postoperative adjuvant platinum doublet chemotherapy. One year and 2 months after surgery, he was diagnosed with gastric and adrenal tumors. Immunohistochemical analysis of the gastric lesion demonstrated TTF-1 positivity, leading to the diagnosis of gastric and adrenal metastatic recurrence of lung cancer. The patient received triple therapy with carboplatin, pemetrexed, and pembrolizumab, followed by maintenance therapy with pemetrexed and pembrolizumab. During treatment, the adrenal metastasis achieved a complete response; however, the gastric lesion showed gradual progression on endoscopic follow-up. As primary gastric cancer could not be ruled out, the patient underwent robot-assisted distal gastrectomy with D2 lymph node dissection and Billroth I reconstruction, 3 years and 4 months following lung resection. Immunohistochemical staining of the gastric tumor revealed adenocarcinoma that was positive for TTF-1 and caudal-related homeodomain protein 2 (CDX2) and negative for napsin A. In contrast, lung cancer tissue was weakly positive for TTF-1 and negative for napsin A and CDX2. Based on the immunohistochemical staining and histological findings, the final diagnosis was primary gastric adenocarcinoma. The postoperative course was uneventful, and maintenance chemotherapy with pemetrexed and pembrolizumab was resumed. Four years and 10 months after cancer surgery, the patient remains in complete response.CONCLUSIONS: This case highlights the diagnostic challenge posed by TTF-1–positive gastric tumors, which may be mistaken for metastatic lesions from lung cancer. As TTF-1 expression is not entirely specific to tissues of lung or thyroid origin, diagnosis should be based on a comprehensive evaluation of morphological and immunohistochemical findings, together with clinical information, including treatment response and disease course.
- 1 January 2026
- Published by Japan Surgical Society in Surgical Case Reports
- Vol. 12 (1) , cr.25-0677
Open AccessPrimary Gastric Adenocarcinoma with Thyroid Transcription Factor-1 Positivity Mimicking Gastric Metastasis from Lung Cancer: A Case Report
INTRODUCTION: Thyroid transcription factor-1 (TTF-1) is a well-established immunohistochemical marker for tumors of lung and thyroid origin. Metastatic adenocarcinomas are often tested for TTF-1 expression to identify their primary site. Herein, we report a rare case of TTF-1–positive primary gastric adenocarcinoma that was initially misdiagnosed and treated as postoperative gastric metastasis from primary lung cancer.CASE PRESENTATION: A 58-year-old man underwent thoracoscopic right upper lobectomy with systemic lymph node dissection for lung cancer of the right upper lobe. The pathological diagnosis was invasive adenocarcinoma (pT2bN0M0, Stage IIA). He received 3 courses of postoperative adjuvant platinum doublet chemotherapy. One year and 2 months after surgery, he was diagnosed with gastric and adrenal tumors. Immunohistochemical analysis of the gastric lesion demonstrated TTF-1 positivity, leading to the diagnosis of gastric and adrenal metastatic recurrence of lung cancer. The patient received triple therapy with carboplatin, pemetrexed, and pembrolizumab, followed by maintenance therapy with pemetrexed and pembrolizumab. During treatment, the adrenal metastasis achieved a complete response; however, the gastric lesion showed gradual progression on endoscopic follow-up. As primary gastric cancer could not be ruled out, the patient underwent robot-assisted distal gastrectomy with D2 lymph node dissection and Billroth I reconstruction, 3 years and 4 months following lung resection. Immunohistochemical staining of the gastric tumor revealed adenocarcinoma that was positive for TTF-1 and caudal-related homeodomain protein 2 (CDX2) and negative for napsin A. In contrast, lung cancer tissue was weakly positive for TTF-1 and negative for napsin A and CDX2. Based on the immunohistochemical staining and histological findings, the final diagnosis was primary gastric adenocarcinoma. The postoperative course was uneventful, and maintenance chemotherapy with pemetrexed and pembrolizumab was resumed. Four years and 10 months after cancer surgery, the patient remains in complete response.CONCLUSIONS: This case highlights the diagnostic challenge posed by TTF-1–positive gastric tumors, which may be mistaken for metastatic lesions from lung cancer. As TTF-1 expression is not entirely specific to tissues of lung or thyroid origin, diagnosis should be based on a comprehensive evaluation of morphological and immunohistochemical findings, together with clinical information, including treatment response and disease course.